The British subsidiary of Indian drug major Cipla Ltd has acquired 51% equity stake in Uganda-based Quality Chemicals Ltd for $30 million (Rs.191 crore) in tranches from its current shareholders. As per the agreement that both companies signed on Thursday, Cipla (EU) Ltd will pay $8 million (Rs.51 crore) upfront and the balance amount of Rs.140 crore in five equal installments of $4.41 million annually to the shareholders. This transaction is expected to be completed by July.
The 18-year-old Kampala-based Quality Chemicals Ltd imports and distributes pharmaceutical and consumer products in the east African nation. Quality also holds 22% equity stake in another Cipla subsidiary in Uganda - Cipla Quality Chemical Industries Ltd.
Cipla Soon to Launch Generic Hepatitis C Drug as Hepcvir
Cipla has signed a licensing agreement with Gilead to manufacture the drug Sofosbuvir and it will be made available as Hepcvir in India.
Advertisement
The company said in a regulatory filing to the Bombay Stock Exchange (BSE), "Post acquisition, our stake in the Ugandan subsidiary will increase to 62.3% from 51.05% and strengthen our presence in the African market."
Quality's turnover declined to Ugandan shilling 14.85 (approximately $4.98 million) billion in calendar year 2014 from 17.02 billion in 2013.
Source: Medindia
Source: Medindia
Cipla and Strides Sign Pact With MMV: Fight Against Malaria
In collaboration with MMV, based in Switzerland, Cipla and Strides Arcolab venture to develop rectal artesunate for pre-referral malaria treatment severe in children.
Advertisement
 Cipla Announces Significant Reduction in Prices of Three More Cancer DrugsMumbai-based pharmaceutical company Cipla has announced that it has cut the price for three more cancer drugs by nearly 64 percent. | Advertisement
|
Cipla Announces Massive Reduction in Prices of Anti-Cancer Drugs
Indian pharmaceutical firm Cipla has announced a massive 76 percent price cut for some of its cancer drugs that are used to treat lung, brain and kidney cancers.
Advertisement
Recommended Readings
Latest General Health News
The Pakistan Ministry has announced the commencement of a nationwide polio vaccination campaign beginning on October 2, aiming to immunize more children.
In a tragic incident, a woman in the US experienced the loss of all her limbs as a result of a bacterial outbreak linked to the consumption of contaminated fish.
FluMos-v2, a unique universal influenza vaccine candidate, undergoing a phase 1 trial at NIH, increases recipients' immunity against many influenza viruses.
In Pakistan, the polio campaign focuses on more than 270,000 children under the age of five years, residing in areas with insufficient vaccine coverage.
Dangers of Wrong Diagnosis: Diagnostic errors in healthcare can increase the risk of permanent disabilities and deaths.
